Last updated July 9, 2020 | By Texas Department of Health State Services
In addition to the DSHS COVID-19 Dashboard, DSHS has made available the following datasets.
Please note that all data are provisional and subject to change. Probable cases are not included in the total case numbers.
Accessible Dashboard Data – Updated Daily (Last updated: 7/9/2020)
This Excel file contains the underlying data currently displayed in the DSHS COVID-19 Dashboard. Data are displayed on multiple tabs and include daily and cumulative case and fatality data, estimated recoveries, statewide hospital data, and case demographics for confirmed cases. Data are overwritten daily.
Data over Time by County – Excel Files Updated Daily (Last Updated: 7/9/2020)
- Cases over Time by County
- Fatalities over Time by County
- Estimated Active Cases over Time by County
- Cumulative Tests over Time by County
County Trends Dashboard – Updated Daily
This dashboard contains daily new case and fatality trends by county, as well as total cases per 1,000 persons by county.
Hospital Data over Time by Trauma Service Area (TSA) – Excel Files Updated Daily (Last Updated: 7/9/2020)
Cumulative Long-Term Care Facility Data by Public Health Region (PHR) – Updated Daily (Last updated: 7/9/2020)
- COVID-19 Outbreaks in Long-Term Care Facilities (HTML) (Excel file)
- Nursing Home Data over Time by PHR (Excel file)
- Assisted Living Facility Data Over Time by PHR (Excel File)
National Data and Projections
U.S. Cases, Data, and Surveillance
This resource from the federal Centers for Disease Control and Prevention (CDC) provides national case counts, fatality counts, estimated hospitalization rates, and provisional death counts.
This resource from the federal Centers for Disease Control and Prevention (CDC) provides national and state-level forecasts of COVID-19 fatalities.
This section of the CDC site contains links to other groups’ forecasts of COVID-19 fatalities.
This resource provides information on CDC efforts to understand more about how many people have been infected with SARS-CoV-2, the virus that causes COVID-19, and how it is spreading through the U.S. population.
This resource from the federal Food and Drug Administration (FDA) describes the agency’s approach to expanding access to serology tests and ensuring the tests are being appropriately validated.
Last updated July 9, 2020